Eosinophil chemotactic activity in bronchoalveolar lavage fluid obtained from Toxocara canis-infected rats

Clinical Immunology and Immunopathology

Volumn 78, Issue 3, 1996, Pages 256-262

  Okada, Kazuyoshi ^a   Fujimoto, Keisaku ^a   Kubo, Keishi ^a   Sekiguchi, Morie ^a   Sugane, Kazuo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 BROMO 5 [N PHENYL N [2 [[2 (1,2,3,4 TETRAHYDRO 2 ISOQUINOLYLCARBONYLOXY)ETHYL]CARBAMOYL]ETHYL]CARBAMOYL] 1 PROPYLPYRIDINIUM NITRATE; 5 [2 (2 CARBOXYETHYL) 3 [6 (4 METHOXYPHENYL) 5 HEXENYLOXY]PHENOXY]VALERIC ACID; INTERLEUKIN 5; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; MONOCLONAL ANTIBODY; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; EOSINOPHIL; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TOXOCARA CANIS; TOXOCARIASIS;

EID: 0029983777     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0037     Document Type: Article

References (26)

1. Glickman, L. T., and Schantz, P. M., Epidemiology and pathogenesis of Zoonotic Toxocariasis. Epidemiol. Rev. 3, 231-250, 1981.
2. Kayes, S. G., and Oaks, J. A., Effect of inoculum size and length of infection on the distribution of Toxocara canis larvae in the mouse. Am. J. Trop. Med. Hyg. 25, 573-580, 1976.
3. Kayes, S. G., Jones, R. E., and Omholt, P. E., Use of bronchoalveolar lavage to compare local pulmonary immunity with the systemic immune response of Toxocara canis-infected mice. Infect. Immun. 55, 2132-2136, 1987.
4. Abe, T., and Nawa, Y., Eosinophil chemotactic factor released from murine bone marrow derived cultured mast cells. Arerugi 39, 69-74, 1990.
5. Nagy, L., Lee, T. H., Goetzl, E. J., Pickett, W. C., and Kay, A. B., Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. Clin. Exp. Immunol. 47, 541-547, 1982.
6. Wardlaw, A. J., Moqbel, R., Cromwell, O., and Kay, A. B., Platelet-activating factor. A potent chemotactic and chemokinetic factors for human eosinophils. J. Clin. Invest. 78, 1701-1706, 1986.
7. Tamura, N., Agrawal, D. K., Suliaman, F. A., and Townley, R. G., Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects. Biochem. Biophys. Res. Commun. 142, 638-644, 1987.
8. Yamaguchi, Y., Hayashi, Y., Sugama, Y., Miura, Y., Kasahara, T., Kitamura, S., Torisu, M., Mita, S., Tominaga, A., Takatsu, K., and Suda, T., Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. J. Exp. Med. 167, 1737-1742, 1988.
9. 4-induced neutrophil functions. Prostaglandins 44, 261-275, 1992.
10. Terashita, Z., Kawamura, M., Takatani, M., Tsushima, S., Imura, Y., and Nishikawa, K., Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. J. Pharmacol. Exp. Ther. 260, 748-755, 1992.
11. Harada, N., Takahashi, T., Matsumoto, M., Kinashi, T., Ohara, J., Kikuchi, Y., Koyama, N., Severinson, E., Yaoita, Y., Honjo, T., Yamaguchi, N., Tominaga, A., and Takatsu, K., Production of monoclonal antibody useful in the molecular characterization of murine T-cell-replacing factor/B-cell growth factor II. Proc. Natl. Acad. Sci. USA 84, 4581-4585, 1987.
12. Colley, D. G., Variations in peripheral blood eosinophil levels in normal and Schistosoma mansoni-infected mice. J. Lab. Clin. Med. 83, 871-876, 1974.
13. Discombe, G., Criteria of eosinophilia. Lancet 1, 195-196, 1946.
14. Oshima, T., Observations of the age resistance, eosinophilia, and larval behavior in the helminth-free beagles infected with Toxocara canis. Jpn. J. Parasitol 25, 447-455, 1976.
15. Koyama, S., Rennard, S. I., Leikauf, G. D., Shoji, S., Essen, S. V., Claassen, L., and Robbins, R. A., Endotoxin stimulates bronchial epithelial cells to release chemotactic factors for neutrophils. J. Immunol. 147, 4293-4301, 1991.
16. Yamaguchi, Y., Matsui, T., Kasahara, T., Etoh, S., Tominaga, A., Takatsu, K., Miura, Y., and Suda, T., In vivo changes of hemopoietic progenitors and the expression of the interleukin 5 gene in eosinophilic mice infected with Toxocara canis. Exp. Hematol. 18, 1152-1157, 1990.
17. de Savigny, D. H., In vitro maintenance of Toxocara canis larvae and a simple method for the production of Toxocara ES antigen for use in serodiagnostic tests for visceral larva migrans. J. Parasitol. 61, 781-782, 1975.
18. Sugane, K., and Oshima, T., Purification and characterization of excretory and secretory antigen of Toxocara canis larvae. Immunology 50, 113-120, 1983.
19. Takamoto, M., and Sugane, K., Mechanisms of eosinophilia in Toxocara canis infected mice: In vitro production of interleukin 5 by lung cells of both normal and congenitally athymic nude mice. Parasite Immunol. 15, 493-500, 1993.
20. Sugane, K., and Oshima, T., Recovery of large numbers of eosinophils from mice infected with Toxocara canis. Am. J. Trop. Med. Hyg. 29, 799-802, 1980.
21. Hirashima, M., Tashiro, K., and Hayashi, H., The appearance of eosinophil-directed chemotactic inhibitory factor in the serum of complete Freund's adjuvant-treated guinea pigs. Cellular Immunol. 89, 113-121, 1984.
22. Tashiro, K., Sakata, K., Hirashima, M., and Hayashi, H., The regulation of tissue eosinophilia. III. In vitro production of eosinophil-directed chemotactic inhibitory factor by T lymphocytes of complete Freund's adjuvant-treated guinea-pigs. Immunology 55, 115-124, 1985.
23. Tanaka, J., and Torisu, M., Anisakis and eosinophil. I. Detection of a soluble factor selectively chemotactic for eosinophils in the extract from Anisakis larvae. J. Immunol. 120, 745-749, 1978.
24. Torisu, M., Hayashi, Y., Yoshida, T., Fujimura, T., and Goya, T., Eosinophilic granuloma formation in anisakiasis. In "Basic Mechanisms of Granulomatous Inflammation" (T. Yoshida and M. Torisu, Eds.), pp. 207-219, Excerpta Medica, Amsterdam, 1989.
25. Lee, T., Lenihan, D. J., Malone, B., Roddy, L. L., and Wasserman, S. I., Increased biosynthesis of platelet-activating factor in activated human eosinophils. J. Biol. Chem. 259, 5526-5530, 1984.
26. Coffmann, R. L., Seymour, B. W. P., Hudak, S., Jackson, J., and Rennick, D., Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245, 308-310, 1989.